September 10, 2019
Canon Medical Systems Corporation (Canon Medical) announces completion of an agreement with US-based FemtoDx, Inc. (FemtoDx) relating to a capital investment based on stock purchase.
Canon Medical, known for its diagnostic imaging solutions, continues to further expand its business into the fields of healthcare IT and bioscience, with a goal to promote better healthcare throughout the world. FemtoDx, is a research and development company with a focus on Point Of Care Testing (POCT) technologies. FemtoDx is currently developing diagnostic methods to detect and notify patients of early signs of possible pathologic events related to heart failure or stroke before they occur, which leverage mobile devices and incorporate AI technologies.
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound and MR, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.
At Canon Medical, we work hand in hand with our partners - our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life. For more information, visit the Canon Medical website: https://global.medical.canon/
© CANON MEDICAL SYSTEMS CORPORATION
© CANON MEDICAL SYSTEMS CORPORATION
The site you see is the Canon Medical Global website. If you choose region / language, we will link to each regional site.